Nevertheless, more efforts are needed to reveal the precise mechanism of how loss of the tumor suppressor PTEN regulates ABCG2 function and further enhances the SP phenotype through the PI3K/Akt pathway in CML. This evidence concerns the gene ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive.